Viewing Study NCT04355520


Ignite Creation Date: 2025-12-25 @ 4:18 AM
Ignite Modification Date: 2026-03-01 @ 5:37 PM
Study NCT ID: NCT04355520
Status: UNKNOWN
Last Update Posted: 2020-04-21
First Post: 2020-04-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of TQ-B3525 Tablets Combined With Fulvestrant Injection in Subjects With HR-positive, HER2-negative and PIK3CA Mutation Advanced Breast Cancer
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module